Personalized Antisense Oligonucleotide Therapy for Participants With TARDBP ALS

​ Conditions: Amyotrophic Lateral Sclerosis (ALS)

Interventions: Drug: nL-TARDB-006

Sponsors: n-Lorem Foundation; Columbia University; Washington University School of Medicine

Enrolling by invitation Conditions: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Drug: nL-TARDB-006
Sponsors: n-Lorem Foundation; Columbia University; Washington University School of Medicine
Enrolling by invitation